Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Equity Average (2016 - 2025)

Nutex Health's Equity Average history spans 14 years, with the latest figure at $296.1 million for Q2 2025.

  • For Q2 2025, Equity Average rose 265.44% year-over-year to $296.1 million; the TTM value through Jun 2025 reached $296.1 million, up 265.44%, while the annual FY2024 figure was $133.8 million, 34.2% up from the prior year.
  • Equity Average for Q2 2025 was $296.1 million at Nutex Health, up from $221.9 million in the prior quarter.
  • Across five years, Equity Average topped out at $371.8 million in Q2 2022 and bottomed at $79.6 million in Q1 2024.
  • The 5-year median for Equity Average is $145.0 million (2021), against an average of $169.8 million.
  • The largest annual shift saw Equity Average soared 6649.27% in 2021 before it crashed 70.71% in 2023.
  • A 5-year view of Equity Average shows it stood at $202.4 million in 2021, then crashed by 37.54% to $126.4 million in 2022, then fell by 27.23% to $92.0 million in 2023, then soared by 45.81% to $134.2 million in 2024, then soared by 120.69% to $296.1 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Equity Average are $296.1 million (Q2 2025), $221.9 million (Q1 2025), and $134.2 million (Q4 2024).